{"nct_id":"NCT05270668","title":"Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2022-03-29","start_date_type":"ACTUAL","primary_completion_date":"2026-05-30","primary_completion_date_type":"ESTIMATED","completion_date":"2029-07-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}